Indication
FGFR1 Gene Translocation
1 clinical trial
1 product
Clinical trial
A Phase II, Multicenter, Single-Arm Study of Pemigatinib in Patients With Metastatic or Unresectable Colorectal Cancer Harboring FGFR AlterationsStatus: Active (not recruiting), Estimated PCD: 2022-05-13
Product
Pemigatinib